Using Magnetic Stimulation to Reduce Nerve Pain and Improve Quality of Life in People with Diabetes

Evaluating the efficacy of repetitive peripheral magnetic stimulation (rPMS) on pain, sensory loss, and quality of life in patients with diabetic neuropathy: A randomized sham control trial. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101402

Enrollment

Registered

2026-01-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: rPMS- Repetitive peripheral magnetic stimulation: application of Repetitive peripheral magnetic stimulation, head in contact with the body for 15mins per session for 3 days per week fo

Eligibility

Inclusion criteria

Inclusion criteria: Type 2 DM patients with duration of diabetes greater than or equal to 5 years Both genders age between 40 to 70 years Pain for more than 3 months PainDETECT questionnaire (score 19 to 38) LANSS score more than 1224

Exclusion criteria

Exclusion criteria: Known history of phantom limb pain. Diabetic complications involving cardiovascular system, visual system and renal system. History of radiculopathy and other types of neuropathies. Any implanted devices (pacemakers) or metal implants at the site of application. Simultaneous treatment with analgesic medications or NSAIDs

Design outcomes

Primary

Measure	Time frame
NPRS, Monofilament foot setTimepoint: baseline, completion of 9 sessions, 1 month and 3 months	—

Secondary

Measure	Time frame
NeuroQOL Questionnaire26Timepoint: baseline, completion of 9 sessions, 1 month and 3 months	—

Countries

India

Contacts

Public ContactSheril P

Institute of Physiotherapy, Srinivas University

thrish22.cp@srinivasuniversity.edu.in9743201400

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026